GLAXF News and Press, GlaxoSmithKline Plc From 05/12/21

Kahn Brothers’ 13F portfolio value increased from $579M to $646M this quarter. Stakes in VOXX International and BlackBerry were decreased during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~45% of the 13F holdings....

Fisher’s 13F portfolio value increased from ~$133.5B to ~$142B in Q1 2021. They increased Walt Disney and Eli Lilly while trimming Taiwan Semi, JD.com, and Pinduoduo. Fisher has a number of small positions in several ETFs/ETNs. For further details see: Tracking Ke...

GlaxoSmithKline plc (GSK) Q1 2021 Earnings Conference Call April 28, 2021, 09:00 AM ET Company Participants Emma Walmsley - CEO Iain Mackay - CFO Luke Miels - President, Global Pharmaceuticals David Redfern - Chief Strategy Officer Brian McNamara - CEO, Consumer Healthcare Hal Barron - Chief ...

The following slide deck was published by GlaxoSmithKline plc in conjunction with their 2021 Q1 earnings call. For further details see: GlaxoSmithKline plc 2021 Q1 - Results - Earnings Call Presentation

Clovis Oncology is a highly volatile stock that rises and falls cyclically. Despite Rubraca's approval for two deadly cancer indications (ovarian and prostate), sales have been increasing modestly. Nevertheless, the latest ARIEL4 data positioned Rubraca to become the first-line dr...

GlaxoSmithKline is a British, international pharma company formed in early 2000, and was the world's sixth-largest pharma company as of 2019. It is the fourth largest stock on the London Stock Exchange, but holds the dubious honor of agreeing to pay the largest settlement by a drug co...

Healthcare is one of the most defensive sectors and often contains strong moats. Fortunately for income investors, there are also numerous high-yield opportunities in the space. We highlight four high-yield healthcare stocks that could richly reward investors. For further de...

GlaxoSmithKline plc (GSK) Barclays Global Healthcare Conference 2021 March 10, 2021 8:35 AM ET Company Participants Deborah Waterhouse - CEO, ViiV Healthcare, GlaxoSmithKline plc Conference Call Participants Emily Field - European Pharmaceuticals Analyst, Barclays Presentation Emily Field Sor...

GlaxoSmithKline plc (GSK) Cowen 41st Annual Health Care Conference March 01, 2021 12:20 PM ET Company Participants Dr. Hal Barron - Chief Scientific Officer, President of R&D Conference Call Participants Steve Scala - Cowen and Company Presentation Steve Scala Good afternoon, and welcome ...

There is growing demand for AI use in drug development. Drug development deals go from $5 million to over $1 billion. Predictive Oncology has a unique platform using real patient samples in its AI process. Predictive Oncology could be undervalued if it can ink large or multipl...